Northwest Biotherapeutics Statistics
Total Valuation
NWBO has a market cap or net worth of 315.93 million. The enterprise value is 390.43 million.
| Market Cap | 315.93M |
| Enterprise Value | 390.43M |
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NWBO has 1.63 billion shares outstanding. The number of shares has increased by 17.26% in one year.
| Current Share Class | 1.63B |
| Shares Outstanding | 1.63B |
| Shares Change (YoY) | +17.26% |
| Shares Change (QoQ) | +2.90% |
| Owned by Insiders (%) | 2.27% |
| Owned by Institutions (%) | 0.05% |
| Float | 1.59B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 229.27 |
| PB Ratio | -6.64 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.63 |
| EV / Sales | 283.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.44 |
Financial Position
The company has a current ratio of 0.06
| Current Ratio | 0.06 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.40 |
| Interest Coverage | -6.89 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -69.33% |
| Return on Invested Capital (ROIC) | -1,310.00% |
| Return on Capital Employed (ROCE) | 575.54% |
| Weighted Average Cost of Capital (WACC) | 1.81% |
| Revenue Per Employee | 13,124 |
| Profits Per Employee | -560,448 |
| Employee Count | 25 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -537,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.71% in the last 52 weeks. The beta is -0.77, so NWBO's price volatility has been lower than the market average.
| Beta (5Y) | -0.77 |
| 52-Week Price Change | -33.71% |
| 50-Day Moving Average | 0.22 |
| 200-Day Moving Average | 0.24 |
| Relative Strength Index (RSI) | 35.33 |
| Average Volume (20 Days) | 2,326,439 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 26.91 |
Income Statement
In the last 12 months, NWBO had revenue of 1.38 million and -58.85 million in losses. Loss per share was -0.04.
| Revenue | 1.38M |
| Gross Profit | -27.41M |
| Operating Income | -59.91M |
| Pretax Income | -60.70M |
| Net Income | -58.85M |
| EBITDA | -57.85M |
| EBIT | -59.91M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 3.04 million in cash and 64.83 million in debt, with a net cash position of -61.79 million or -0.04 per share.
| Cash & Cash Equivalents | 3.04M |
| Total Debt | 64.83M |
| Net Cash | -61.79M |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | -47.57M |
| Book Value Per Share | -0.04 |
| Working Capital | -86.18M |
Cash Flow
In the last 12 months, operating cash flow was -44.76 million and capital expenditures -1.50 million, giving a free cash flow of -46.27 million.
| Operating Cash Flow | -44.76M |
| Capital Expenditures | -1.50M |
| Depreciation & Amortization | 2.06M |
| Net Borrowing | 29.99M |
| Free Cash Flow | -46.27M |
| FCF Per Share | -0.03 |
Margins
| Gross Margin | n/a |
| Operating Margin | -4,347.90% |
| Pretax Margin | -4,404.86% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NWBO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.26% |
| Shareholder Yield | -17.26% |
| Earnings Yield | -18.63% |
| FCF Yield | -14.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 26, 2012. It was a reverse split with a ratio of 0.0625.
| Last Split Date | Sep 26, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.0625 |
Scores
NWBO has an Altman Z-Score of -27.86 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -27.86 |
| Piotroski F-Score | 4 |